Bram Slütter
Bram Slütter
Assistant Professor
Verified email at lacdr.leidenuniv.nl
Title
Cited by
Cited by
Year
Mechanistic study of the adjuvant effect of biodegradable nanoparticles in mucosal vaccination
B Slütter, L Plapied, V Fievez, MA Sande, A des Rieux, YJ Schneider, ...
Journal of Controlled Release 138 (2), 113-121, 2009
1922009
Administration routes affect the quality of immune responses: A cross-sectional evaluation of particulate antigen-delivery systems
D Mohanan, B Slütter, M Henriksen-Lacey, W Jiskoot, JA Bouwstra, ...
Journal of Controlled Release 147 (3), 342-349, 2010
1912010
Nasal vaccination with N-trimethyl chitosan and PLGA based nanoparticles: Nanoparticle characteristics determine quality and strength of the antibody response in mice against …
B Slütter, S Bal, C Keijzer, R Mallants, N Hagenaars, I Que, E Kaijzel, ...
Vaccine 28 (38), 6282-6291, 2010
1702010
Lung airway-surveilling CXCR3hi memory CD8+ T cells are critical for protection against influenza A virus
B Slütter, LL Pewe, SM Kaech, JT Harty
Immunity 39 (5), 939-948, 2013
1452013
Conjugation of ovalbumin to trimethyl chitosan improves immunogenicity of the antigen
B Slütter, PC Soema, Z Ding, R Verheul, W Hennink, W Jiskoot
Journal of Controlled Release 143 (2), 207-214, 2010
1442010
Rational design of nasal vaccines
B Slütter, N Hagenaars, W Jiskoot
Journal of drug targeting 16 (1), 1-17, 2008
1322008
Dynamics of influenza-induced lung-resident memory T cells underlie waning heterosubtypic immunity.
B Slütter, NBB Van, G Abboud, SM Varga, S Salek-Ardakani, JT Harty
Science immunology 2 (7), 2017
1182017
Towards tailored vaccine delivery: needs, challenges and perspectives
JP Amorij, GFA Kersten, V Saluja, WF Tonnis, WLJ Hinrichs, B Slütter, ...
Journal of controlled release 161 (2), 363-376, 2012
1172012
Orchestrating immune responses: How size, shape and rigidity affect the immunogenicity of particulate vaccines
N Benne, J van Duijn, J Kuiper, W Jiskoot, B Slütter
Journal of Controlled Release 234, 124-134, 2016
1062016
Efficient induction of immune responses through intradermal vaccination with N-trimethyl chitosan containing antigen formulations
SM Bal, B Slütter, E van Riet, AC Kruithof, Z Ding, GFA Kersten, W Jiskoot, ...
Journal of controlled release 142 (3), 374-383, 2010
1002010
NLRP3 inflammasome inhibition by MCC950 reduces atherosclerotic lesion development in apolipoprotein E–deficient mice—brief report
T van der Heijden, E Kritikou, W Venema, J van Duijn, PJ van Santbrink, ...
Arteriosclerosis, thrombosis, and vascular biology 37 (8), 1457-1461, 2017
992017
Dual role of CpG as immune modulator and physical crosslinker in ovalbumin loaded N-trimethyl chitosan (TMC) nanoparticles for nasal vaccination
B Slutter, W Jiskoot
Journal of Controlled Release 148 (1), 117-121, 2010
882010
Covalently stabilized trimethyl chitosan-hyaluronic acid nanoparticles for nasal and intradermal vaccination
RJ Verheul, B Slütter, SM Bal, JA Bouwstra, W Jiskoot, WE Hennink
Journal of Controlled Release, 2011
872011
Adjuvanted, antigen loaded N-trimethyl chitosan nanoparticles for nasal and intradermal vaccination: adjuvant-and site-dependent immunogenicity in mice
SM Bal, B Slütter, R Verheul, JA Bouwstra, W Jiskoot
European Journal of Pharmaceutical Sciences, 2011
842011
PLGA, PLGA-TMC and TMC-TPP Nanoparticles Differentially Modulate the Outcome of Nasal Vaccination by Inducing Tolerance or Enhancing Humoral Immunity
C Keijzer, B Slütter, R van der Zee, W Jiskoot, W van Eden, F Broere
PLoS ONE 6 (11), e26684, 2011
722011
Adjuvant effect of cationic liposomes and CpG depends on administration route
B Slutter, SM Bal, D Zhi, W Jiskoot, JA Bouwstra
Journal of Controlled Release, 2011
712011
PLGA particulate delivery systems for subunit vaccines: linking particle properties to immunogenicity
AL Silva, PC Soema, B Slütter, F Ossendorp, W Jiskoot
Human vaccines & immunotherapeutics 12 (4), 1056-1069, 2016
652016
Small is beautiful: N-trimethyl chitosan–ovalbumin conjugates for microneedle-based transcutaneous immunisation
SM Bal, B Slütter, W Jiskoot, JA Bouwstra
Vaccine 29 (23), 4025-4032, 2011
602011
Antigen− adjuvant nanoconjugates for nasal vaccination: an improvement over the use of nanoparticles?
B Slütter, SM Bal, I Que, E Kaijzel, C Löwik, J Bouwstra, W Jiskoot
Molecular pharmaceutics 7 (6), 2207-2215, 2010
582010
Hepatitis B surface antigen nanoparticles coated with chitosan and trimethyl chitosan: impact of formulation on physicochemical and immunological characteristics
M Tafaghodi, V Saluja, GFA Kersten, H Kraan, B Slütter, JP Amorij, ...
Vaccine 30 (36), 5341-5348, 2012
572012
The system can't perform the operation now. Try again later.
Articles 1–20